In what could become a new twist in the ongoing patent dispute over the Apple Watch’s Blood Oxygen sensor, the CEO of Masimo, ...

Masimo CEO Joe Kiani may have waged and won a patent dispute against Apple over its blood oxygen sensor, he has stepped down ...

Masimo CEO Joe Kiani stepped down following a two-year skirmish with an activist investor that ejected him from his own board ...

Masimo Corporation (NASDAQ:MASI) shares are trading higher on Wednesday. Michelle Brennan, a current member of Masimo’s Board ...

Masimo said on Wednesday founder Joe Kiani has decided to step down as the medical device maker's CEO, days after ...

Masimo today confirmed the resignation of founder and CEO Joe Kiani after last week's shareholder vote ousted him as board ...

Michelle Brennan was named acting CEO of the patient monitoring company following Joe Kiani’s defeat in a proxy battle with an activist investor.

In mid-2023, the hedge fund nominated Brennan—as well as the firm’s managing partner, Quentin Koffey—to replace two members ...

In one of the most shocking moves in Orange County’s business history, Masimo Corp. shareholders voted Sept. 19 to oust Joe ...

Shares of Masimo (NASDAQ: MASI) are trading nearly 3% higher early on Friday after activist investor Politan Capital Management, owner of a 9% stake in the company, disclosed its ...

Politan Capital Management said its candidates captured two board seats in Thursday’s shareholder vote, citing a preliminary analysis.

Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a ...